| Product Code: ETC13172384 | Publication Date: Apr 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 150 | No. of Figures: 55 | No. of Tables: 32 |
North America Sickle Cell Anemia Testing and Screening Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 North America Sickle Cell Anemia Testing and Screening Market Overview |
3.1 North America Regional Macro Economic Indicators |
3.2 North America Sickle Cell Anemia Testing and Screening Market Revenues & Volume, 2021 & 2031F |
3.3 North America Sickle Cell Anemia Testing and Screening Market - Industry Life Cycle |
3.4 North America Sickle Cell Anemia Testing and Screening Market - Porter's Five Forces |
3.5 North America Sickle Cell Anemia Testing and Screening Market Revenues & Volume Share, By Countries, 2021 & 2031F |
3.6 North America Sickle Cell Anemia Testing and Screening Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.7 North America Sickle Cell Anemia Testing and Screening Market Revenues & Volume Share, By Age Group, 2021 & 2031F |
3.8 North America Sickle Cell Anemia Testing and Screening Market Revenues & Volume Share, By Sector Type, 2021 & 2031F |
4 North America Sickle Cell Anemia Testing and Screening Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 North America Sickle Cell Anemia Testing and Screening Market Trends |
6 North America Sickle Cell Anemia Testing and Screening Market, 2021 - 2031 |
6.1 North America Sickle Cell Anemia Testing and Screening Market, Revenues & Volume, By Technology, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 North America Sickle Cell Anemia Testing and Screening Market, Revenues & Volume, By Hemoglobin Electrophoresis, 2021 - 2031 |
6.1.3 North America Sickle Cell Anemia Testing and Screening Market, Revenues & Volume, By POC, 2021 - 2031 |
6.1.4 North America Sickle Cell Anemia Testing and Screening Market, Revenues & Volume, By HPLC, 2021 - 2031 |
6.2 North America Sickle Cell Anemia Testing and Screening Market, Revenues & Volume, By Age Group, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 North America Sickle Cell Anemia Testing and Screening Market, Revenues & Volume, By Newborn Screening (12 months and below), 2021 - 2031 |
6.2.3 North America Sickle Cell Anemia Testing and Screening Market, Revenues & Volume, By Adult Screening (25 to 60 years), 2021 - 2031 |
6.2.4 North America Sickle Cell Anemia Testing and Screening Market, Revenues & Volume, By Others (1 to 25 & above 60 years), 2021 - 2031 |
6.3 North America Sickle Cell Anemia Testing and Screening Market, Revenues & Volume, By Sector Type, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 North America Sickle Cell Anemia Testing and Screening Market, Revenues & Volume, By Government Labs, 2021 - 2031 |
6.3.3 North America Sickle Cell Anemia Testing and Screening Market, Revenues & Volume, By Private Labs, 2021 - 2031 |
6.3.4 North America Sickle Cell Anemia Testing and Screening Market, Revenues & Volume, By Corporate Labs, 2021 - 2031 |
6.3.5 North America Sickle Cell Anemia Testing and Screening Market, Revenues & Volume, By PPP (Public-Private-Partnerships), 2021 - 2031 |
7 North America Sickle Cell Anemia Testing and Screening Market, By Countries, 2021 - 2031 |
7.1 Overview & Analysis |
7.2 North America Sickle Cell Anemia Testing and Screening Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.2.1 United States (US) Sickle Cell Anemia Testing and Screening Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.2.2 Canada Sickle Cell Anemia Testing and Screening Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.2.3 Rest of North America Sickle Cell Anemia Testing and Screening Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.3 North America Sickle Cell Anemia Testing and Screening Market Revenues & Volume Share, By Age Group, 2021 & 2031F |
7.3.1 United States (US) Sickle Cell Anemia Testing and Screening Market, Revenues & Volume, By Age Group, 2021 - 2031 |
7.3.2 Canada Sickle Cell Anemia Testing and Screening Market, Revenues & Volume, By Age Group, 2021 - 2031 |
7.3.3 Rest of North America Sickle Cell Anemia Testing and Screening Market, Revenues & Volume, By Age Group, 2021 - 2031 |
7.4 North America Sickle Cell Anemia Testing and Screening Market, Revenues & Volume, By Sector Type, 2021 - 2031 |
7.4.1 United States (US) Sickle Cell Anemia Testing and Screening Market, Revenues & Volume, By Sector Type, 2021 - 2031 |
7.4.2 Canada Sickle Cell Anemia Testing and Screening Market, Revenues & Volume, By Sector Type, 2021 - 2031 |
7.4.3 Rest of North America Sickle Cell Anemia Testing and Screening Market, Revenues & Volume, By Sector Type, 2021 - 2031 |
8 North America Sickle Cell Anemia Testing and Screening Market Key Performance Indicators |
9 North America Sickle Cell Anemia Testing and Screening Market - Export/Import By Countries Assessment |
10 North America Sickle Cell Anemia Testing and Screening Market - Opportunity Assessment |
10.1 North America Sickle Cell Anemia Testing and Screening Market Opportunity Assessment, By Countries, 2021 & 2031F |
10.2 North America Sickle Cell Anemia Testing and Screening Market Opportunity Assessment, By Technology, 2021 & 2031F |
10.3 North America Sickle Cell Anemia Testing and Screening Market Opportunity Assessment, By Age Group, 2021 & 2031F |
10.4 North America Sickle Cell Anemia Testing and Screening Market Opportunity Assessment, By Sector Type, 2021 & 2031F |
11 North America Sickle Cell Anemia Testing and Screening Market - Competitive Landscape |
11.1 North America Sickle Cell Anemia Testing and Screening Market Revenue Share, By Companies, 2022 |
11.2 North America Sickle Cell Anemia Testing and Screening Market Competitive Benchmarking, By Operating and Technical Parameters |
12 Top 10 Company Profiles |
13 Recommendations |
14 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here